Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Average Rating of “Buy” from Analysts
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has received a consensus recommendation of “Buy” from the seven analysts that are covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have issued ratings on the stock in the last […]
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has received a consensus recommendation of “Buy” from the seven analysts that are covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have issued ratings on the stock in the last […]
